$NBIO News... https://finance.yahoo.com/news/nasc
Post# of 21197
https://finance.yahoo.com/news/nascent-begins...00290.html
*Announced today that the Company has enrolled the first patient of the fifth and final cohort of its Phase I clinical trial to evaluate Pritumumab ("PTB" as a treatment for Primary and Metastatic Brain Cancers.
*This cohort of patients will likely be the final one in this trial.